In the domain of the central nervous system, the effects of hyperoxemia manifest with a particular concern: the heightened risk of generalized tonic-clonic seizures. However, it's crucial to note that such seizures are a rarity outside the realm of hyperbaric therapy. This observation serves as a reminder of the nuanced relationship between therapeutic interventions and physiological responses.
Understanding the balance between oxygen's life-sustaining role and its potential to precipitate adverse neurological outcomes under specific conditions (like hyperbaric therapy) is key. This underscores the broader principle that medical interventions, while often beneficial, carry inherent risks that must be navigated with care and precision.
| System | Effect | Notes |
|---|---|---|
| Respiratory | Absorptive atelectasis as high FiO2 displaces alveolar nitrogen and alveoli collapse | Worsens hypoxemia and reduces vital capacity, with reductions up to 20 percent after hyperoxic exposure. |
| Respiratory | Established atelectasis | Lowering FiO2 will not reverse it; proactive titration to the minimal necessary FiO2 is crucial. |
| Respiratory | Airway injury at very high levels (FiO2 of 0.9): symptoms akin to tracheobronchitis and airway inflammation on bronchoscopy | Increased reactive oxygen intermediates in exhaled gas, irrespective of pre-existing lung conditions. |
| Respiratory | Accentuated hypercapnia, notably in chronic conditions such as COPD | Generally moderate; does not usually precipitate CO2 narcosis or respiratory failure. |
| Cardiovascular | Coronary vasoconstriction; microscopic myocardial necrosis in animal studies | — |
| Cardiovascular | May reduce stroke volume and cardiac output, with relative bradycardia and increased systemic vascular resistance | Clinical significance is drawn from limited human data; susceptibility appears more pronounced in patients with heart failure. |
| Central nervous system | Generalized tonic-clonic seizures | A rarity outside the realm of hyperbaric therapy. |
